[1]李黎.3项肾小球滤过率内源性标志物的临床应用评价[J]. 国际检验医学杂志,2012 ,33 (2):170-171.[2]陈爱珍,孙秀丽.CystatinC和β-2微球蛋白检测在肾脏病中的应用[J]. 医学综述,2009 ,15 (17): 2583-2586.[3]National Committee for Clinical Standards. Method comparison and bias estimation using patient samples; approved guideline-second edition[S]. EP9-A2,NCCLS,2002.[4]刘欣.血清胱抑素C测定及临床意义[J]. 国际检验医学杂志,2010 ,31 (5): 473-474.[5]班副植,黄承乐.血清胱抑素C测定的方法学研究进展[J]. 检验医学与临床,2009 ,6 (15): 1299-1300.[6]Hossain MA,Emara M,El Moselhi H,et al. Comparing measures of cystatin C in human sera by three methods[J]. Am J Nephrol,2009 ,29 (5): 381-391.[7]丛玉隆.临床实验室管理[M]. 北京:中国医药科技出版社,2004: 43-53.[8]谢媛,李丹,徐丙根,等.两种测定血清半胱氨酸蛋白酶抑制剂C方法的结果比较[J].检验医学,2008,23(5):520-522.[9]National Committee for Clinical Standards. Method comparison and bias estimation using patient samples; approved guideline[S]. EP9-A,NCCLS,1995.[10]王建琼,牛华,刘莉.透射比浊法和散射比浊法测定血清胱抑素C的方法学评价[J]. 国际检验医学杂志,2011 ,32(3): 340.[11]International Organization for Standardization. In vitro diagnostic medical devices. Measurement of quantities in biological samples. Metrological traceability of values assigned to calibrators and control materials[S]. ISO 17511,ISO, 2003.[12]Grubb A,Blirup-Jensen S,Lindstrm V. First certified reference material for cystatin C in human serum ERM-DA471/IFCC[J]. Clin Chem Lab Med,2010,48 (11): 1619-1621.[13]Voskoboev NV,Larson TS,Rule AD,et al. Importance of cystatin C assay standardization[J]. Clin Chem,2011,57 (8): 1209-1211.